Thursday, November 12, 2026
Biotech

FDA Flags Rare Eye Risk with Weight Loss Drugs

The FDA is warning patients about a rare eye condition linked to popular weight loss shots.

Millions of Americans take weight loss shots every week. Now, health officials see a new safety risk. The FDA warns that drugs like Wegovy and Zepbound might link to a rare eye problem.

The condition damages the optic nerve and can cause sudden vision loss. Agency officials studied safety reports from patients across the country. They found more cases of this eye issue than expected among people taking the shots.

These drugs help people manage diabetes and cut weight. Even with the new warning, the condition remains rare. Doctors still view these shots as helpful tools for many patients.

Watch your eyesight if you take these medications. Call your doctor right away if your vision blurs. Always check with your doctor before you change your daily medicine.

Source: CNBC

#Biotech#FDA#Healthcare#Weight Loss#GLP-1

More from Biotech